103935-47-3

Basic information

• Product Name: 2-Bromoethyl trifluoromethanesulphonate
• Synonyms: 2-Bromoethyl trifluoromethanesulphonate;1,1,1-TrifluoroMethanesulfonic acid 2-broMo-ethyl ester;2-Bromoethyl triflate;2-broMoethyl trifluoroMethanesulfonate;Methanesulfonic acid, trifluoro-, 2-broMoethyl ester
• CAS NO: 103935-47-3
• Molecular Formula: C₃H₄BrF₃O₃S
• Molecular Weight: 257
• Mol File: 103935-47-3.mol
• Article Data: 27

Chemical Properties

• Boiling Point: 188.733 °C at 760 mmHg
• Flash Point: 67.944 °C
• Appearance: /
• Density: 1.904 g/cm³
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-Bromoethyl trifluoromethanesulphonate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Bromoethyl trifluoromethanesulphonate(103935-47-3)
• EPA Substance Registry System: 2-Bromoethyl trifluoromethanesulphonate(103935-47-3)

Safety Data

• Hazardous Substances Data: 103935-47-3(Hazardous Substances Data)

Usage

General Description

2-Bromoethyl trifluoromethanesulphonate is a chemical compound with the formula C4H6BrF3O3S. It is a highly reactive and toxic compound that is commonly used as a reagent in organic synthesis for the functionalization of alcohols and amines. Its main use is as an alkylating agent, reacting with nucleophilic functional groups to form carbon-carbon or carbon-nitrogen bonds. It is also used in the pharmaceutical industry for the synthesis of various drugs and as a cross-linking agent in the production of polymers. However, it is important to handle 2-Bromoethyl trifluoromethanesulphonate with care due to its toxic and corrosive properties.

Upstream product

• 108-48-5 2,6-dimethylpyridine 
• 141072-57-3 1-bromoethanol 
• 358-23-6 trifluoromethylsulfonic anhydride 
• 540-51-2 2-bromoethanol 
• 2923-28-6 silver trifluoromethanesulfonate 
• 106-93-4 ethylene dibromide 
• 74-85-1 ethene 
• 33454-82-9 lithium trifluoromethanesulfonate 
• 35895-70-6 tetrabutylammonium trifluoromethylsulfonate 

Downstream Products

• 189452-25-3 (2R,4S)-3-benzoyl-4-bromoethyl-4-methyl-2-phenyl-1,3-oxazolidin-5-one 
• 247129-85-7 (2-bromoethyl)(diphenyl)sulfonium trifluoromethanesulfonate 
• 190003-04-4 tert-butyl (3S)-3-(benzylamino)-3-phenylpropanoate 
• 1278457-70-7 methyl (2S)-2-(benzyl-(2-bromo-ethyl)-amino)-3-(4-tertbutoxy-phenyl)-propionate 
• 890022-42-1 (2S,4R)-4-Benzyl-4-(2-bromo-ethyl)-2-tert-butyl-5-oxo-oxazolidine-3-carboxylic acid allyl ester 
• 405906-74-3 {(Z)-(8S,11S)-16-Benzyloxy-3-[2-(2-bromo-ethoxy)-phenyl]-5-cyano-8-isopropyl-10-oxo-18-oxa-6,9-diaza-tricyclo[11.3.1.1^4,7]octadeca-1⁽¹⁶⁾,2,4,6,13⁽¹⁷⁾,14-hexaen-11-yl}-carbamic acid tert-butyl ester 
• 323192-77-4 (2R,4R)-2-phenyl-4-(2-bromoethyl)-4-((4-phenylmethoxy)phenyl)-5-oxo-3-oxazolidinecarboxylic acid methyl ester 
• 216772-52-0 2,3,4,5-tetra-O-benzyl-N-(2-bromoethyl)-D-arabinonamide 
• 187409-52-5 (2R)-1-(tert-butyloxycarbonyl)-2-{[(tert-butyldimethylsilyl)oxy]methyl}-3-(phenylsulfonyl)pyrrolidine 
• 106114-43-6 8-<4-(4-fluorophenyl)-4-oxobutyl>-1-phenyl-4-(2-fluoroethoxy)-1,3,8-triazaspiro<4.5>dec-3-ene 

Relevant articles and documents

Vinyl Thianthrenium Tetrafluoroborate: A Practical and Versatile Vinylating Reagent Made from Ethylene

The use of vinyl electrophiles in synthesis has been hampered by the lack of access to a suitable reagent that is practical and of appropriate reactivity. In this work we introduce a vinyl thianthrenium salt as an effective vinylating reagent. The bench-stable, crystalline reagent can be readily prepared from ethylene gas at atmospheric pressure in one step and is broadly useful in the annulation chemistry of (hetero)cycles, N-vinylation of heterocyclic compounds, and palladium-catalyzed cross-coupling reactions. The structural features of the thianthrene core enable a distinct synthesis and reactivity profile, unprecedented for other vinyl sulfonium derivatives.

SPIRO-SULFONIMIDAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEUKEMIA-1 (MCL-1) PROTEIN

The disclosure is directed to compounds of Formula (I). Pharmaceutical compositions comprising compounds of Formula (I) as well as methods of their use and preparation, are also described.

TRIOXACARCIN-ANTIBODY CONJUGATES AND USES THEREOF

Provided herein are trioxacarcin-antibody drug conjugates of Formula (I): and pharmaceutically acceptable salts thereof, wherein R7 is -L-B, wherein L is a linking group, and B is an antibody or antibody fragment. Also provided are methods of preparing the antibody-drug conjugates, pharmaceutically acceptable compositions thereof, and methods of their use and treatment. Further provided are precursors to the trioxacarcin- antibody drug conjugates (e.g., compounds of Formula (II), novel trioxacarcins without an antibody conjugated thereto), pharmaceutical compositions thereof, and methods of their use and treatment.